Humacyte issues 47.62M shares at $1.05 per share
Humacyte has priced its underwritten public offering of common stock.
The company is selling 47.62M shares at $1.05 per share.
The gross proceeds from the offering are expected to be approximately $50M, before deducting underwriting discounts and commissions.